Table of contents

Research Article

• Virological and serological aspects of hepatitis B and the delta agent. (1 January, 1993)

  G Hess
• Hepatitis C: looking at a virus that hasn't been seen. (1 January, 1993)

  L R Overby
• Progress on the control of hepatitis B infection through immunisation. (1 January, 1993)

  M A Kane
• Epidemiology and long term prognosis of hepatitis C virus infection in Japan. (1 January, 1993)

  M Yano, H Yatsuhashi, O Inoue, K Inokuchi, M Koga
• Community acquired viral hepatitis B and C in the United States. (1 January, 1993)

  M J Alter
• Diagnostic markers of viral hepatitis B and C. (1 January, 1993)

  C Trépo, F Zoulim, C Alonso, M A Petit, C Pichoud, L Vitvitski
• Viral markers in the treatment of hepatitis B and C. (1 January, 1993)

  H Schmilovitz-Weiss, M Levy, N Thompson, G Dusheiko
• Problems in diagnosing viral hepatitis. (1 January, 1993)

  F Bonino, G Colloredo Mels, G Bellati, G Ideo, F Oliveri, P Colombatto, M R Brunetto
• Polymerase chain reaction for the diagnosis of viral hepatitis B and C. (1 January, 1993)

  C Bréchot
• Role of screening in prevention and treatment. (1 January, 1993)

  M Kane, M Alter, R Esteban, M Rizzetto
• Hepatitis B: transmission and natural history. (1 January, 1993)

  R P Perrillo
• Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France. (1 January, 1993)

  S Ranger, P Martin, M C Roussanne, F Denis
• Vertical transmission of hepatitis C virus (HCV) detected by HCV-RNA analysis. (1 January, 1993)

  T Kuroki, S Nishiguchi, K Fukuda, N Ikeoka, R Murata, G Isshiki, S Tomoda, S Ogita, T Monna, K Kobayashi
• Hepatitis C virus antibody positive blood donors. (1 January, 1993)

  D Mutimer, J Shaw, R Harrison, F Ala, J Neuberger, E Elias
• Anti-HCV seroprevalence in pregnant women in France. (1 January, 1993)

  F Roudot-Thoraval, J M Pawlotsky, L Deforges, P P Girollet, D Dhumeaux
• Hepatitis C virus infection among Greek renal transplant patients. (1 January, 1993)

  I Vafiadis, J Boletis, H Papastathi, J Delladetsima, C Stathakis, A Hatzakis, A Kostakis, G Vosnides
• Detection of HCV-RNA in saliva of patients with chronic hepatitis C. (1 January, 1993)

  P Couzigou, L Richard, F Dumas, L Schouler, H Fleury
• Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results. (1 January, 1993)

  G Baskin, R DiNello, A Polito, S Quan, W S Lee, J Wu, M Nelles, S Lee
• Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b. (1 January, 1993)

  J Genesca, J I Esteban, J Quer, L L Viladomiu, A Gonzalez, R Esteban, J Guardia
• Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease. (1 January, 1993)

  O Yokosuka, M Omata, Y Ito, M Ohto
• Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis. (1 January, 1993)

  J M Pawlotsky, L Deforges, S Bretagne, C André, J M Métreau, V Thiers, E S Zafrani, M Goossens, J Duval, J P Mavier
• Historical treatment of chronic hepatitis B and chronic hepatitis C. (1 January, 1993)

  P Ferenci
• Biological basis for the clinical use of interferon. (1 January, 1993)

  F Dianzani
• Is there a role for interferon in acute viral hepatitis? (1 January, 1993)

  R Esteban
• Viral hepatitis management. Standards for the future. Case studies. (1 January, 1993)

  S Sherlock, S Hadziyannis, M Nishioka, R P Perrillo, E R Schiff, C Trépo
• Interferon alfa-2b therapy in children with chronic hepatitis B. (1 January, 1993)

  E M Sokal, S Wirth, P Goyens, A Depreterre, C Cornu
• A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up. (1 January, 1993)

  V Perez, J Findor, H Tanno, J Sordá
• Interferon for hepatitis B: US experience. (1 January, 1993)

  R P Perrillo
• Low dose alpha interferon treatment in chronic hepatitis B virus infection. (1 January, 1993)

  R Müller, R Baumgarten, R Markus, M Schulz, H Wittenberg, B Hintsche-Kilger, J D Fengler, P von Wussow, H Meisel, H Klein
• Low dose interferon alfa-2b for chronic hepatitis B in Asian countries. (1 January, 1993)

  E Mauracher
• Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results. (1 January, 1993)

  Y Bayraktar, B Uzunalimoglu, S Arslan, T Koseoglu, B Kayhan, H Telatar
• Interferon treatment of chronic active hepatitis B: effect of a six month treatment regimen. (1 January, 1993)

  M Raptopoulou, H Orphanou, H Vrettou, E Akribiadis, L Chadzikonstantinou, G Goulis
• Interferon alfa-2b for decompensated liver disease caused by either chronic hepatitis B or C: preliminary results of a pilot study. (1 January, 1993)

  M Dimopoulou, K Fafoutis, K Basiliou, J Ketikoglou, G Karvountzis
• Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine. (1 January, 1993)

  P Marcellin, N Boyer, J F Colin, M Martinot-Peignoux, V Lefort, S Matheron, S Erlinger, J P Benhamou
• Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis. (1 January, 1993)

  G Visco, L Alba, S Grisetti, P Guarascio, P Narciso, P Sette, C Struglia, G Tossini, V Tozzi
• Initial results with recombinant interferon alfa-2b in patients with chronic hepatitis C: the United States experience. (1 January, 1993)

  G L Davis
• Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment. (1 January, 1993)

  J M Métreau
• High dose interferon treatment in chronic hepatitis C. (1 January, 1993)

  S Iino
• Benelux multicentre trial of alpha interferon treatment for chronic hepatitis C: standard v high dose treatment monitored by biochemical and virological markers (interim analysis). Benelux Multicentre Trial Study Group. (1 January, 1993)
• Interferon alfa for chronic hepatitis C in haemophiliacs. (1 January, 1993)

  M Makris, F E Preston, D R Triger, J C Underwood, L Westlake, M I Adelman
• Long term treatment of chronic hepatitis C with interferon alfa-2b: disappearance of HCV-RNA in a pilot study of eight haemophilia patients. (1 January, 1993)

  D Bresters, E P Mauser-Bunschoten, H T Cuypers, J H Han, P L Jansen, R A Chamuleau, M Houghton, H W Reesink
• Recombinant interferon alfa-2b treatment in chronic non-A, non-B/type C hepatitis. (1 January, 1993)

  V De Conca, S Mesiti, E Vallarino, A Mornese, M Dodero
• Clinical and histological evaluation of interferon alfa-2b in the treatment of chronic hepatitis C. (1 January, 1993)

  C Panella, A Francavilla, D Conte, I Tatulli, F Rubini
• Treatment of chronic hepatitis C with recombinant interferon alfa-2b. (1 January, 1993)

  M Piazza, R Orlando, G Tosone, D Tiseo, M C Conte, F Minervini, G Santoro, F Scordino, D Vitale
• Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis. (1 January, 1993)

  N C Tassopoulos, M G Koutelou, G Papatheodoridis, H Polychronaki, I Delladetsima, T Giannikakis, A Todoulos, A Toliopoulos, A Hatzakis
• Quantitative hepatitis C virus RNA and liver histology in chronic hepatitis C patients treated with interferon alfa. (1 January, 1993)

  G Yamada, M Takahashi, H Endo, T Doi, R Miyamoto, H Shimomura, K Yamamoto, T Tsuji
• Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C. (1 January, 1993)

  C De Bac, F Grimaldi, C Clementi, F Duca, D Livoli, G Taliani
• Treatment of chronic hepatitis C with recombinant interferon alfa-2b for nine months. (1 January, 1993)

  R Pérez, R Pravia, A Linares, M González, M Rodríguez, J L Lombraña, S Riestra, A Suárez, L Rodrigo
• Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C. (1 January, 1993)

  R Pérez, R Pravia, A Linares, M Rodríguez, J L Lombraña, A Suárez, S Riestra, C A Navascués, L Rodrigo
• Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion. (1 January, 1993)

  M Colombo, P Lampertico, M Rumi
• Alpha interferon treatment of chronic hepatitis C in beta-thalassaemia. (1 January, 1993)

  V Di Marco, O Lo Iacono, M Capra, S Grutta, C Ciaccio, C Gerardi, A Maggio, D Renda, P Almasio, R Pisa
• Interferon alfa-2b in mixed cryoglobulinaemia: a controlled crossover trial. (1 January, 1993)

  C Ferri, E Marzo, G Longombardo, L La Civita, F Lombardini, D Giuggioli, R Vanacore, A M Liberati, A Mazzoni, F Greco
• Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon. (1 January, 1993)

  P Bedossa, T Poynard, P Mathurin, G Lemaigre, J C Chaput
• Treatment algorithms for hepatitis B and C. (1 January, 1993)

  E R Schiff